🇺🇸 FDA
Pipeline program

TAK-755

TAK-755-2002

Phase 2 mab active

Quick answer

TAK-755 for Acute Ischemic Stroke is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Acute Ischemic Stroke
Phase
Phase 2
Modality
mab
Status
active

Clinical trials